Skip to main content

Advertisement

Table 1 Patients’ characteristics and clinical features (n = 280)

From: Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors

 No. of patients%
Age at time of breast cancer diagnosis
  ≤ 354215
 36–408128.9
 41–4515756.1
Age at study entry
  ≤ 3582.9
 36–40269.2
 41–457627.1
 46–5014652.1
  > 50238.6
Education
 Primary4716.9
 Secondary18767.0
 Tertiary and higher qualification4516.2
Marital Status
 Single4315.4
 Married Partner21677.1
 Divorced155.4
 Widowed62.1
Family income*
  < HK$5000279.6
 HK$5000-25,00015053.6
  > HK$25,00010336.8
BMI at study entry (kg/m2) [25]
  < 18.5 (Underweight)113.9
 18.5–22.9 (Normal)12344.0
 23.0–24.9 (Overweight)6222.1
  > 25 (Obese)8430.0
Staging
 I8831.4
 II16558.9
 III279.6
Hormonal receptor
 ER positive20372.5
 PR positive18766.8
HER overexpression4716.8
Breast surgery:
 Lumpectomy9533.9
 Mastectomy18566.1
Axillary nodal dissection27698.6
Adjuvant radiotherapy18666.4
Adjuvant chemotherapy regimen:
 Taxane-containing7928.2
 Non-taxane-containing20171.8
Adjuvant chemotherapy lasting longer than 64 days19168.2
Time since last adjuvant treatment**
 3 to < 5 years16057.1
 5 to < 10 years12042.9
Ever received adjuvant tamoxifen21476.4
On adjuvant tamoxifen at study entry11541.1
Adjuvant targeted therapy with trastuzumab82.9
Utilization of traditional Chinese medicine since diagnosis8329.6
Menopausal status at study entry
 Premenopausal11240
 Peri/Post- menopausal16860
  1. *HK$ = Hong Kong dollars; HK$1 is equivalent to US$ 0.128
  2. ** Only include chemotherapy/radiotherapy or trastuzumab